Oseltamivir resistance in an influenza A (H3N2) virus isolated from an immunocompromised patient during the 2014-2015 influenza season in Alberta, Canada

被引：11

作者：

Chaudhry, Ahsan ^{[1
,2
]}

Bastien, Nathalie ^{[3
]}

Li, Yan ^{[3
]}

Scott, Allison ^{[4
]}

Pabbaraju, Kanti ^{[5
]}

Stewart, Douglas ^{[1
,2
]}

Wong, Sallene ^{[5
]}

Drews, Steven J. ^{[6
,7
]}

机构：

[1] Univ Calgary, Dept Oncol, Calgary, AB, Canada

[2] Univ Calgary, Dept Med, Calgary, AB, Canada

[3] Natl Microbiol Lab, Winnipeg, MB, Canada

[4] Surveillance & Assessment Accountabil & Performan, Edmonton, AB, Canada

[5] ProvLab Alberta Calgary, Calgary, AB, Canada

[6] ProvLab Alberta Edmonton, Edmonton, AB, Canada

[7] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada

来源：

INFLUENZA AND OTHER RESPIRATORY VIRUSES | 2016年 / 10卷 / 06期

关键词：

H3N2; influenza; neuraminidase inhibitors; reduced susceptibility; resistance; sequence analysis; NEURAMINIDASE INHIBITORS; SUSCEPTIBILITY; ASSAYS;

D O I：

10.1111/irv.12415

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

This manuscript describes the identification of an oseltamivir-resistant influenza A (H3N2) virus in a respiratory specimen collected from an immunocompromised patient in Alberta, Canada, during the 2014-2015 influenza season. Following treatment with oseltamivir, neuraminidase (NA) gene sequencing indicated the presence of an R292K mutation. Phenotypic susceptibility testing by the NA-Star assay indicated a highly reduced inhibition by oseltamivir and normal inhibition by zanamivir. The use of zanamivir following identification of the oseltamivir-resistant strain, combined with a partial immune reconstitution, was followed by a suggested decrease in the nasopharyngeal viral load in the nasopharynx and clinical improvement of the patient.

引用

页码：532 / 535

页数：4

共 50 条

[31] Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season [J].

Price, Ashley M. ;

Flannery, Brendan ;

Talbot, H. Keipp ;

Grijalva, Carlos G. ;

Wernli, Karen J. ;

Phillips, C. Hallie ;

Monto, Arnold S. ;

Martin, Emily T. ;

Belongia, Edward A. ;

McLean, Huong Q. ;

Gaglani, Manjusha ;

Mutnal, Manohar ;

Geffel, Krissy Moehling ;

Nowalk, Mary Patricia ;

Tartof, Sara Y. ;

Florea, Ana ;

McLean, Callie ;

Kim, Sara S. ;

Patel, Manish M. ;

Chung, Jessie R. .

CLINICAL INFECTIOUS DISEASES, 2023, 76 (08) :1358-1363

[32] Combinations of 1,8-cineol and oseltamivir for the treatment of influenza virus A (H3N2) infection in mice [J].

Lai, Yan-ni ;

Li, Yun ;

Fu, Lin-chun ;

Zhao, Fang ;

Liu, Ni ;

Zhang, Feng-xue ;

Xu, Pei-ping .

JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (07) :1158-1167

[33] Genetic diversity of influenza A(H3N2) viruses in Northern Cameroon during the 2014-2016 influenza seasons [J].

Njifon, Hermann Landry Munshili ;

Monamele, Chavely Gwladys ;

Vernet, Marie-Astrid ;

Njankouo, Mohamadou Ripa ;

Deweerdt, Louis ;

Nono, Raphael ;

Kenmoe, Sebastien ;

Mbacham, Wilfred ;

Njouom, Richard .

JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (08) :1400-1407

[34] Moderate influenza vaccine effectiveness against influenza A(H1N1)pdm09 virus and low effectiveness against A(H3N2) virus among older adults during 2013-2014 influenza season in Beijing, China [J].

Zhang, Li ;

Pan, Yang ;

Ma, Chunna ;

Duan, Wei ;

Sun, Ying ;

Wu, Shuangsheng ;

Zhang, Man ;

Tian, Yi ;

Zheng, Yang ;

Yang, Peng ;

Wang, Quanyi .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (06) :1323-1330

[35] Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada [J].

Abed, Y ;

Hardy, I ;

Li, Y ;

Boivin, G .

JOURNAL OF MEDICAL VIROLOGY, 2002, 67 (04) :589-595

[36] Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014-15 [J].

Gherasim, Alin ;

Pozo, Francisco ;

de Mateo, Salvador ;

Aspiritxaga Gamarra, Inma ;

Garcia-Cenoz, Manuel ;

Vega, Tomas ;

Martinez, Eva ;

Gimenez, Jaume ;

Castrillejo, Daniel ;

Larrauri, Amparo .

VACCINE, 2016, 34 (20) :2371-2377

[37] Outbreak of Variant Influenza A(H3N2) Virus in the United States [J].

Jhung, Michael A. ;

Epperson, Scott ;

Biggerstaff, Matthew ;

Allen, Donna ;

Balish, Amanda ;

Barnes, Nathelia ;

Beaudoin, Amanda ;

Berman, LaShondra ;

Bidol, Sally ;

Blanton, Lenee ;

Blythe, David ;

Brammer, Lynnette ;

D'Mello, Tiffany ;

Danila, Richard ;

Davis, William ;

de Fijter, Sietske ;

DiOrio, Mary ;

Durand, Lizette O. ;

Emery, Shannon ;

Fowler, Brian ;

Garten, Rebecca ;

Grant, Yoran ;

Greenbaum, Adena ;

Gubareva, Larisa ;

Havers, Fiona ;

Haupt, Thomas ;

House, Jennifer ;

Ibrahim, Sherif ;

Jiang, Victoria ;

Jain, Seema ;

Jernigan, Daniel ;

Kazmierczak, James ;

Klimov, Alexander ;

Lindstrom, Stephen ;

Longenberger, Allison ;

Lucas, Paul ;

Lynfield, Ruth ;

McMorrow, Meredith ;

Moll, Maria ;

Morin, Craig ;

Ostroff, Stephen ;

Page, Shannon L. ;

Park, Sarah Y. ;

Peters, Susan ;

Quinn, Celia ;

Reed, Carrie ;

Richards, Shawn ;

Scheftel, Joni ;

Simwale, Owen ;

Shu, Bo .

CLINICAL INFECTIOUS DISEASES, 2013, 57 (12) :1703-1712

[38] The resurgence of influenza A/H3N2 virus in Australia after the relaxation of COVID-19 restrictions during the 2022 season [J].

Wang, Xinye ;

Walker, Gregory ;

Kim, Ki W. ;

Stelzer-Braid, Sacha ;

Scotch, Matthew ;

Rawlinson, William D. .

JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (09)

[39] Combined efficacy of oseltamivir, isoprinosine and ellagic acid in influenza A(H3N2)-infected mice [J].

Pavlova, Elitsa L. ;

Simeonova, Lora S. ;

Gegova, Galina A. .

BIOMEDICINE & PHARMACOTHERAPY, 2018, 98 :29-35

[40] Neurologic Manifestations of Influenza A(H3N2) Infection in Children During the 2016-2017 Season [J].

Rao, Suchitra ;

Martin, Jan ;

Ahearn, M. Alex ;

Osborne, Christina ;

Moss, Angela ;

Dempsey, Amanda ;

Dominguez, Samuel R. ;

Weinberg, Adriana ;

Messacar, Kevin B. .

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2020, 9 (01) :71-74

← 1 2 3 4 5 →